Multiple moving parts have caused a shortage of eggs, starting with avian influenza and demand, David Murray writes.

Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting the bird flu outbreaks that continue to devastate flocks.

The US Department of Agriculture (USDA) Center for Veterinary Biologics (CVB) has issued a conditional license for an avian influenza vaccine, H5N2 subtype, killed virus. The vaccine, manufactured by Zoetis, is labeled for use in chickens.

Three years into a nationwide avian influenza outbreak that has forced millions of egg-laying birds to be killed after becoming infected, Hilliker’s Ranch in Lakeside has been able to keep producing day in and day out with a little luck and a lot of effort around sanitation.

PARSIPPANY, N.J., February 14, 2025--(BUSINESS WIRE)--Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype ...

A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An infectious diseases expert comments.

Center for Veterinary Biologics (CVB) issued Zoetis Inc (NYSE:ZTS) a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labeled for use in chickens. The conditional license was granted on the demonstration of safety,

The vaccine from Zoetis, Avian Influenza Vaccine, H5N2 Subtype, Killed Virus, is for poultry and has been demonstrated to be safe, pure, and to have a reasonable expectation of efficacy

A veterinary pharmaceutical company said they have received a conditional license for a bird flu vaccine to be used on chickens, potentially marking the first step toward mitigating a disease that has affected more than 150 million birds in the United States since 2022.

Zoetis (ZTS) announced that the U.S. Department of Agriculture, Center for Veterinary Biologics, has issued the company a conditional license